NCT03400202View on ClinicalTrials.gov

Physiopathologic Aspects and Quality of Life in Participants With Eye Dark Circles

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

February 2, 2018

Primary Completion Date

November 7, 2018

Study Completion Date

November 7, 2018

Conditions
Periorbital Hyperpigmentation
Interventions
DEVICE

Skin imaging

Non-invasive in vivo skin imaging will be taken with the VivoSight Ox Optical Coherence Tomography (OCT).

OTHER

Facial cleanser

Facial cleanser prior to procedures.

Trial Locations (1)

92612

SkinMedica Clinical Research and Innovation Center, Irvine

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY